Advanced Tests for Early Detection Favors Oral Cancer Treatment Market

Disclaimer: All content and media on our website Werdube is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Read full disclaimer

Emergence of New Advanced Tests for Early Detection Favors Oral Cancer Treatment Market

A Glance at Oral Cancer

Oral cancer aka mouth cancer generally takes place on the surfaces of the tongue, cheek, lips, tonsils, salivary glands andn gums. It is a type of neck and head cancer that occurs in the form of a tumor within the mouth. Oral cancers can either be malignant or benign.

Benign tumors can be taken care of by a surgery. Around 90% of total malignant oral cancers cover squamous cell carcinoma that can spread to various other parts of the human body. The Oral Cancer Foundation reveals that annually, almost 55,000 oral cancer cases are detected and over 10,650 people lose lives in the United States. Oral cancer forms around 4% of the overall cancer cases and leads to 3.2% deaths in only U.S.

In majority of the western nations, the prominence of oral cancer is 3% to 7% of the total cases of cancer. In several Asia Pacific countries, oropharyngeal cancer is highly common among the men population in comparison to the female populace. The National Cancer Institute says that 70% of patients affected by oral cancer can survive for more than five while 80% to 95% of individuals with Stage 1 or 2 cancer have high survival rates of more than 5 years.

Oral Cancer Treatment Market Status Quo

Surging cases of oral cancers, rise in healthcare spending, and the growth in risk factors including advancing age, and mounting prevalence of HPV16 enhance the oral cancer treatment market size. Moreover, heightened consumption of tobacco across the globe has been favorable for the oral cancer treatment market as well.

Reports by the World Health Organization (WHO) confirm that the overall tobacco use in the world is around 5 million which is rising every year while deaths worldwide owing to intake of tobacco reached 10 million by 2020. Accelerated consumption of alcohol all over the world remains another factor giving rise to oral cancer. This should propel the market position in subsequent years.

Furthermore, the rapidly mushrooming patient population along with significant investments made by the governments for offering more efficient oral cancer treatment work in favor of the worldwide market as well. But ignoring the early symptoms of the disease and the general lack of awareness among the mass, especially in emerging countries can most likely deter market growth in the years to come.

Technology Analysis

The market has been prevailing at a solid pace given the extensive use of some of the most modern technologies during the treatment process, given that the oral cancer treatment procedures are completely based on extremely scientific procedures and techniques. Considering this there has been a surge in the use of cutting-edge tools as well as machines that elevate the effectiveness of the treatment procedure.

To be more specific, the entire oral cancer treatment procedure generally involves chemotherapy, targeted therapy, radiation therapy, and various surgeries that are based on chemical processes as well as the utilization of UV radiation. The technological system that is emerging rapidly in the oral cancer treatment market includes robotics as well as artificial intelligence systems that offer a timely and exact location of cancer, following which the treatment process is carried out to remove the tumor by reducing every minimizing every possible threat related to the treatment while ensuring non-return of cancer.

COVID-19 Scenario

Dentists are vital in the diagnosis of oral cancer as they carefully screen for any oral cavities. However, the shutdown of the dental clinics, post-pandemic lockdown, caused a reduction in the number of screening activities, which had an adverse effect on oral cancer treatment.

There was a delay in elective surgeries owing to the COVID-19 outbreak to avoid cross-contamination. Essential surgeries were carried out, only for potentially malignant or extremely malignant lesions. All other surgeries had to be postponed.

Chemotherapy to be a Major Treatment Type for Oral Cancer

There are a number of treatments for oral cancer, namely immunotherapy, targeted therapy, and chemotherapy.

The chemotherapy segment is currently in the lead, accounting for more than two-thirds of the total market for oral cancer treatment. This segment should continue to maintain its leadership all through the forecast period. This particular type of treatment is given regularly/every day for a total course of six weeks, depending on the cancer size and its spread. On the other hand, the targeted therapy segment can capture the fastest growth rate in the coming years.

Hospital Pharmacies to Remain Dominant as the Top End-User in the Market

The major end-users in the worldwide market are academic institutes, research organizations, and hospital pharmacies.

The highest growth is exhibited by the hospital pharmacies segment, which accounts for over half of the overall oral cancer treatment market. With more and more patients being admitted to the hospitals for various forms of treatments, it is easier to receive the required drugs and medicines prescribed right from the pharmacies at the hospitals as compared to other outlets. This has resulted in huge revenue generation.

Status Quo of Oral Cancer Treatment Market in Various Regions

In view of the heightened preference for surgical therapies to treat oral cancer and the surge in government investments in research & development for better treatments, the North American market has emerged as the global leader. Other growth-inducing factors can be the rise in healthcare spending and the massive prominence of oral cancer in the region. Rising intake of tobacco, mounting number of smokers, and the presence of a thriving healthcare industry add considerably to the market value in the United States.

The Asia Pacific market for oral cancer treatment can anticipate expansion at the fastest pace in the years ahead. Surging tobacco usage and the number of smokers, rising focus on improving the healthcare infrastructure and the heightened awareness level among the public about different types of cancer augment the market position. On top of this, supportive government regulations and policies along with the growth in people’s disposal income drive the expansion rate of the oral cancer treatment market within the region.

Recent Developments

March 2022

Working on improving oral cancer diagnosis and treatment, a researchers’ group from the Queen Mary University of London has come up with the first polymerase chain reaction test that detects oral cancer. Other than yielding rapid and efficient results, this test known as the quantitative Malignant Index Diagnosis System or qMIDS, is easy to use and is cost-effective.